Q9BYF1 (ACE2_HUMAN) Homo sapiens (Human)
Angiotensin-converting enzyme 2 UniProtKBInterProSTRINGInteractive Modelling
805 aa; Sequence (Fasta)
Molecule Processing
| Processed angiotensin-converting enzyme 2 |
It is possible new templates exist for this target since these models were created.
Sequence Features
| 375 | Proton acceptor | ||
| 505 | Proton donor | ||
| 374 | Zinc; catalytic | ||
| 378 | Zinc; catalytic | ||
| 402 | Zinc; catalytic | ||
| 26 | K -> R (polymorphism; dbSNP:rs4646116) VAR_023082 dbSNP | ||
| 468 | I -> V (polymorphism) VAR_083726 | ||
| 638 | N -> S (polymorphism; dbSNP:rs183135788) VAR_023083 dbSNP | ||
| 720 | N -> D (polymorphism) VAR_083727 | ||
| 741-761 | Helical | ||
| 133-141 | |||
| 344-361 | |||
| 530-542 | |||
| 21-606 | Peptidase M2, peptidyl-dipeptidase A IPR001548PF01401 | ||
| 617-770 | Collectrin domain IPR031588PF16959 |
Sequence Alignments
Experimental structures
| Description | Oligo-state | Ligands | Structure | Range |
|---|---|---|---|---|
| ACE2-B0AT1 complex |
Heteromer Q695T7; | 14×NAG; 10×NAG; 4×3PH; 2×ZN; | 6m18 | |
| Assess | ||||
| ACE2-B0AT1 complex, open conformation |
Heteromer Q695T7; | 6m1d | ||
| Assess | ||||
| The 2019-nCoV RBD/ACE2-B0AT1 complex |
Heteromer P0DTC2; Q695T7; | 14×NAG; 2×NAG; 10×NAG; 2×LEU; 2×ZN; | 6m17 | |
| Assess | ||||
| Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) |
Heteromer | 3×NAG; 1×CL; 1×ZN; | 1r42 | |
| Assess | ||||
| Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 |
Heteromer P0DTC2; | 1×ZN; 1×CL; 5×NAG; | 6m0j | |
| Assess | ||||
| Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus huma… |
Heteromer P59594; Q56NL1; | 5×NDG; 2×ZN; 2×CL; 1×NAG; | 3d0g | |
| Assess | ||||
| Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus human … |
Heteromer P59594; | 1×ZN; 1×CL; | 3sci | |
| Assess | ||||
| Crystal structure of spike protein receptor-binding domain from the 2005-2006 SARS coronavirus cive… |
Heteromer P59594; Q56NL1; | 5×NDG; 2×ZN; 2×CL; 1×NAG; | 3d0i | |
| Assess | ||||
| Structure of SARS coronavirus spike receptor-binding domain complexed with its receptor |
Heteromer P59594; | 1×NAG; 4×NAG; 1×ZN; 1×CL; | 2ajf | |
| Assess | ||||
| Inhibitor Bound Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) |
Heteromer | 2×NAG; 1×CL; 1×ZN; 1×XX5; | 1r4l | |
| Assess | ||||
| Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet … |
Heteromer P59594; | 1×ZN; 1×CL; | 3scj | |
| Assess | ||||
| Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet … |
Heteromer P59594; Q56NL1; | 1×ZN; 1×CL; | 3sck | |
| Assess | ||||
| Crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain co… |
Heteromer P59594; Q56NL1; | 1×ZN; 1×CL; | 3scl | |
| Assess | ||||
| Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus cive… |
Heteromer P59594; Q56NL1; | 5×NDG; 2×ZN; 2×CL; 1×NAG; | 3d0h | |
| Assess | ||||
| Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39 |
Heteromer P0DTC2; | 2×NAG; 2×NAG; 1×NAG; 1×NAG; 1×ZN; 1×SO4; | 7dmu | |
| Assess | ||||
| Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… |
Heteromer P59594; | 6acg | ||
| Assess | ||||
| Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… |
Heteromer P59594; | 6acj | ||
| Assess | ||||
| Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… |
Heteromer P59594; | 6ack | ||
| Assess | ||||
| SARS-CoV-2 S-ACE2 complex |
Heteromer P0DTC2; | 18×NAG; 36×NAG; | 7df4 | |
| Assess | ||||
| Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2 |
Heteromer P0DTC2; | 4×NAG; 1×ZN; | 6lzg | |
| Assess | ||||
| Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2 |
Heteromer P0DTC2; P59594; | 3×NAG; 2×NAG; 1×ZN; 1×CL; 1×EDO; 1×NAG; | 6vw1 | |
| Assess | ||||
| Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human … |
Heteromer Q6Q1S2; | 8×NAG; | 3kbh | |
| Assess | ||||
| ACE2-RBD Focused Refinement Using Symmetry Expansion of Applied C3 for Triple ACE2-bound SARS-CoV-2… |
Heteromer P0DTC2; | 2×NAG; 5×NAG; | 7kmb | |
| Assess | ||||
| Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 |
Heteromer P0DTC2; | 5×NAG; 46×NAG; | 7knb | |
| Assess | ||||
| Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4 |
Heteromer P0DTC2; | 4×NAG; 53×NAG; | 7kmz | |
| Assess | ||||
| Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 |
Heteromer P0DTC2; | 8×NAG; 55×NAG; | 7kms | |
| Assess | ||||
| Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5 |
Heteromer P0DTC2; | 6×NAG; 44×NAG; | 7kne | |
| Assess | ||||
| Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5 |
Heteromer P0DTC2; | 4×NAG; 48×NAG; | 7knh | |
| Assess | ||||
| Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5 |
Heteromer P0DTC2; | 6×NAG; 56×NAG; | 7kni | |
| Assess | ||||
| SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction |
Heteromer P0DTC2; | 7a95 | ||
| Assess | ||||
| SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction |
Heteromer P0DTC2; | 7a96 | ||
| Assess | ||||
| SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound |
Heteromer P0DTC2; | 7a97 | ||
| Assess | ||||
| SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound |
Heteromer P0DTC2; | 23×NAG; 1×ZN; | 7a94 | |
| Assess | ||||
| Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) |
Heteromer P0DTC2; | 1×NAG; 7×NAG; 1×ZN; | 7a91 | |
| Assess | ||||
| SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound |
Heteromer P0DTC2; | 7a98 | ||
| Assess | ||||
| Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement) |
Heteromer P0DTC2; | 1×NAG; 7×NAG; 1×ZN; | 7a92 | |
| Assess | ||||
| S protein of SARS-CoV-2 in complex bound with T-ACE2 |
Heteromer P0DTC2; | 35×NAG; 34×NAG; | 7ct5 | |
| Assess | ||||
| SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound |
Heteromer P0DTC2; | 17×NAG; 36×NAG; | 7kj2 | |
| Assess | ||||
| SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound |
Heteromer P0DTC2; | 20×NAG; 40×NAG; | 7kj3 | |
| Assess | ||||
| SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound |
Heteromer P0DTC2; | 24×NAG; 42×NAG; | 7kj4 | |
| Assess | ||||
| SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles |
Heteromer P59594; | 9×NAG; 7×NAG; 11×NAG; 6×NAG; | 6cs2 | |
| Assess | ||||
| Importin alpha bound to the C-terminus of ACE2 |
Heteromer P52293; | 7jvo | ||
| Assess | ||||
Homology models
| Oligo-state | QMEAN | Template | Range | Seq id (%) | Ligands |
|---|---|---|---|---|---|
|
Heteromer P0DTC2; | -0.23 | 6m0j.1.A | 100.00 | 1×ZN; | |
| Assess | |||||
|
Heteromer P0DTC2; | -0.45 | 6lzg.1.A | 100.00 | 1×NAG; 1×ZN; | |
| Assess | |||||
|
Heteromer P0DTC2; | -0.69 | 6vw1.2.A | 96.19 | 1×EDO; | |
| Assess | |||||
|
Heteromer P0DTC2; | -1.95 | 7a94.1.D | 99.89 | 7×NAG; 1×ZN; | |
| Assess | |||||
|
Heteromer P0DTC2; | -3.98 | 6acg.1.D | 84.55 | ||
| Assess | |||||